Ironjustic
Mon, Dec-12-05, 17:16
<<snip>> None of these patients developed hepatocellular
carcinoma (HCC). <<snip>>
http://cancerres.aacrjournals.org/cgi/content/abstract/-
61/24/8697
Clinical Investigations
Normalization of Elevated Hepatic
8-Hydroxy-2'-Deoxyguanosine Levels in
Chronic Hepatitis C Patients by Phlebotomy and Low Iron Diet1
Junji Kato, Masayoshi Kobune, Tokiko Nakamura, Ganji Kuroiwa,
Kohichi Takada, Rishu Takimoto, Yasuhiro Sato, Koshi Fujikawa,
Minoru Takahashi, Tetsuji Takayama, Tatsuru Ikeda and Yoshiro
Niitsu2 Fourth Department of Internal Medicine [J. K., T. N.,
G. K., K. T., R. T=2E, Y. S., K. F., M. T., T. T., Y. N.] and
Department of Molecular Medicine [M. K.], Sapporo Medical
University School of Medicine, and Department of Clinical
Pathology, Sapporo Medical University Hospital
[T. I.], Sapporo 060-8543, Japan
Accumulation of 8-hydroxy-2'-deoxyguanosine (8-OHdG) in DNA,
which may result from the continuous reactive oxygen species
(ROS) generation associated with chronic inflammation, has
been reported in various human preneoplastic lesions and in
cancerous tissues. However, no direct causative relationship
between the 8-OHdG formation and carcinogenesis has been thus
far demonstrated in humans. Directly proving the causality
requires showing that depletion of 8-OHdG levels in tissue by
interfering with ROS generation results in a reduction in
cancer. Chronic hepatitis C virus (HCV) infection is
associated with a high risk of hepatocellular carcinoma (HCC).
Several studies on patients with chronic HCV have shown that
hepatic iron overload is attributable to liver injury and that
iron depletion improved serum aminotransferase levels. Excess
iron is known to generate ROS within cells, which causes
mutagenic lesions, such as 8-OHdG. In this study, therefore,
we have evaluated whether therapeutic iron reduction
(phlebotomy and low iron diet) with a long-term follow-up (6
years) would decrease the hepatic 8-OHdG levels and the risk
of HCC development in patients with chronic HCV. Patients (34)
enrolled were those who had undergone standard IFN therapy but
had no sustained response. Quantitative immunohistochemistry
using the KS-400 image analyzing system and electrochemical
detection was used for 8-OHdG detection. With this treatment,
elevated hepatic 8-OHdG levels in patients with chronic
hepatitis C (8.3 =B1 4.6/105 dG) significantly decreased to
almost normal levels (2.2 =B1 0.9/105 dG; P < 0.001) with
concomitant improvement of hepatitis severity, including
fibrosis, whereas HCV titers were unaffected. None of these
patients developed HCC. Thus, long-term iron reduction therapy
in patients with chronic hepatitis C may potentially lower the
risk of progression to HCC.
Who loves ya. Tom
Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com
Man Is A Herbivore!
http://pages.ivillage.com/ironjustice/manisaherbivore
DEAD PEOPLE WALKING
http://pages.ivillage.com/ironjustice/deadpeoplewalking
carcinoma (HCC). <<snip>>
http://cancerres.aacrjournals.org/cgi/content/abstract/-
61/24/8697
Clinical Investigations
Normalization of Elevated Hepatic
8-Hydroxy-2'-Deoxyguanosine Levels in
Chronic Hepatitis C Patients by Phlebotomy and Low Iron Diet1
Junji Kato, Masayoshi Kobune, Tokiko Nakamura, Ganji Kuroiwa,
Kohichi Takada, Rishu Takimoto, Yasuhiro Sato, Koshi Fujikawa,
Minoru Takahashi, Tetsuji Takayama, Tatsuru Ikeda and Yoshiro
Niitsu2 Fourth Department of Internal Medicine [J. K., T. N.,
G. K., K. T., R. T=2E, Y. S., K. F., M. T., T. T., Y. N.] and
Department of Molecular Medicine [M. K.], Sapporo Medical
University School of Medicine, and Department of Clinical
Pathology, Sapporo Medical University Hospital
[T. I.], Sapporo 060-8543, Japan
Accumulation of 8-hydroxy-2'-deoxyguanosine (8-OHdG) in DNA,
which may result from the continuous reactive oxygen species
(ROS) generation associated with chronic inflammation, has
been reported in various human preneoplastic lesions and in
cancerous tissues. However, no direct causative relationship
between the 8-OHdG formation and carcinogenesis has been thus
far demonstrated in humans. Directly proving the causality
requires showing that depletion of 8-OHdG levels in tissue by
interfering with ROS generation results in a reduction in
cancer. Chronic hepatitis C virus (HCV) infection is
associated with a high risk of hepatocellular carcinoma (HCC).
Several studies on patients with chronic HCV have shown that
hepatic iron overload is attributable to liver injury and that
iron depletion improved serum aminotransferase levels. Excess
iron is known to generate ROS within cells, which causes
mutagenic lesions, such as 8-OHdG. In this study, therefore,
we have evaluated whether therapeutic iron reduction
(phlebotomy and low iron diet) with a long-term follow-up (6
years) would decrease the hepatic 8-OHdG levels and the risk
of HCC development in patients with chronic HCV. Patients (34)
enrolled were those who had undergone standard IFN therapy but
had no sustained response. Quantitative immunohistochemistry
using the KS-400 image analyzing system and electrochemical
detection was used for 8-OHdG detection. With this treatment,
elevated hepatic 8-OHdG levels in patients with chronic
hepatitis C (8.3 =B1 4.6/105 dG) significantly decreased to
almost normal levels (2.2 =B1 0.9/105 dG; P < 0.001) with
concomitant improvement of hepatitis severity, including
fibrosis, whereas HCV titers were unaffected. None of these
patients developed HCC. Thus, long-term iron reduction therapy
in patients with chronic hepatitis C may potentially lower the
risk of progression to HCC.
Who loves ya. Tom
Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com
Man Is A Herbivore!
http://pages.ivillage.com/ironjustice/manisaherbivore
DEAD PEOPLE WALKING
http://pages.ivillage.com/ironjustice/deadpeoplewalking